Orthofix International | OFIX - Ordinary Share Capital


Orthofix International reported $39.83M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Accuray USD 100K 1000 Sep/2024
AngioDynamics USD 41.57M 127K Sep/2025
Artivion USD 47.84M 468K Dec/2025
AtriCure USD 49.79M 91K Dec/2025
Dexcom USD 385.9M 1.1M Mar/2026
EDAP TMS EUR 37.39M 0 Sep/2025
Globus Medical USD 135.06M 449K Dec/2025
Inogen USD 23K 0 Dec/2023
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.82M 69K Mar/2026
J&J USD 2.41B 1.74M Dec/2025
Medtronic USD 1.28B 1.38M Dec/2025
Mesa Laboratories USD 349.53M 3.53M Sep/2024
Orthofix International USD 39.83M 315K Dec/2025
Plus Therapeutics USD 138.68M 7.07M Dec/2025
Smith & Nephew USD 875.96M 1.61M Dec/2025
STAAR Surgical USD 49.78M 377K Mar/2026
Stryker USD 382.98M 584K Mar/2026
Surmodics USD 14.3M 13.58M Jun/2025
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.26M 70K Mar/2026
Veracyte USD 79.79M 743K Mar/2026
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026